Cloning, expressing of exendin-4 analogue and bioactivity analysis in vivo.
- Author:
Taiming LI
1
;
Chunjiao GU
;
Xiaoyu GE
;
Zhezhe LI
;
Dan WANG
;
Yanhong MA
;
Tao LIU
;
Meiyou ZHANG
;
Li LI
;
Jingjing LIU
Author Information
1. State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, Jiangsu, China. taimingli@163.com
- Publication Type:Journal Article
- MeSH:
Animals;
Cloning, Molecular;
Escherichia coli;
genetics;
metabolism;
Gene Transfer Techniques;
Hypoglycemic Agents;
metabolism;
pharmacology;
Insulin;
blood;
Male;
Mice;
Mice, Inbred ICR;
Peptides;
genetics;
pharmacology;
Recombinant Fusion Proteins;
biosynthesis;
genetics;
pharmacology;
Venoms;
biosynthesis;
genetics;
pharmacology
- From:
Chinese Journal of Biotechnology
2012;28(7):877-886
- CountryChina
- Language:Chinese
-
Abstract:
To construct, express and purify Exendin-4 analogue and detect its biological activity in vivo. Insert gene sequence into fusion partner ofpED plasmid which is helped to purification, entitled the new recombinant plasmid 5 Exendin-4 analogue polypeptide gene and fusion partner gene was linked by acid hydrolysisgene, transformed to E. coli BL21 and the fusion protein was induced by lactose. After acid hydrolysis, the Exendin-4 analogue polypeptide separated from fusion chaperon. Anion charge chromatography were used to further purification. 6 to 8 week-old ICR mice were injected (s.c) with Exendin-4 analogue, blood glucose and plasma insulin level was detected in different period after oral glucose tolerance test. The results show that high expression of inclusion body was induced by lactose, which accounted for 40% of germ proteins, the Exendin-4 analogue was obtained with the purity of 91.8% after being purified by anion charge chromatography. Bioactivity assay showed that the level of blood glucose of mouse which treated with exendin-4 analogue was obviously decreased to normal (P < 0.01), and the level of plasma insulin was increased obviously (P < 0.01).
